DI
RVMD icon

Disciplined Investments’s Revolution Medicines RVMD Stock Holding History

Disciplined Investments’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2
Closed -$54 – 1260
2023
Q2 		$54 Buy
2
+1
+100% +$25 ﹤0.01% 1656
2023
Q1 		$22 Buy
+1
New +$25 ﹤0.01% 1669

Other funds holding RVMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Disciplined Investments's RVMD Position: Q3 2023 in Review

Disciplined Investments sold out of Revolution Medicines (RVMD) in Q3 2023, closing a stake of 2 shares — an estimated $54 sold.

Disciplined Investments first reported a position in RVMD in Q1 2023 and held it in 2 quarters. The position peaked at $54 in Q2 2023. 168 funds tracked by Wall St. Rank hold RVMD as of Q3 2023.

  • Disciplined Investments reported no remaining Revolution Medicines position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 2 Revolution Medicines shares in Q3 2023, an estimated $54.
  • Disciplined Investments first reported a position in Revolution Medicines in Q1 2023 and held it in 2 quarters.
  • Disciplined Investments's Revolution Medicines position peaked at $54 in Q2 2023.
  • 168 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.